Latest News about Pasithea Therapeutics Corp/
Recent news which mentions Pasithea Therapeutics Corp/
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
From Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
Pasithea Therapeutics Receives AUD $1 Million Research Award Following Recent Acquisition
July 18, 2022
Tickers
KTTA
From Benzinga
Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024
April 01, 2022
Tickers
KTTA
From Benzinga
Pasithea Partners With Glimpse Group To Co-Develop VR Environments For Patients With Psychiatric Disorders
March 10, 2022
From Benzinga
Pasithea Therapeutics Announces Plans To Open Three New Clinics In The UK By Mid-2022
February 24, 2022
Tickers
KTTA
From Benzinga
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
January 05, 2022
From Benzinga
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
November 17, 2021
Tickers
KTTA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
